查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1430043

胰島素輸送設備市場規模：按類型、最終用戶分類 - 區域展望、競爭策略、細分市場預測（~2033 年）

Insulin Delivery Devices Market Size- By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 224 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

2033年，胰島素輸送設備市場規模預計將成長至701.4億美元，預測期內年複合成長率為8.71%。

胰島素輸送設備市場受到 COVID-19 爆發的嚴重影響。 I 型糖尿病患者受 COVID-19 的影響更大。由於免疫系統已經被削弱，接觸 COVID-19 會使病情迅速惡化。他們也可能比健康人更容易出現嚴重併發症。

本報告調查了全球胰島素輸送設備市場，並提供了市場概況，市場影響因素和市場機會分析，市場規模趨勢和預測，各個細分市場和地區的詳細分析，競爭形勢以及主要企業總結。

目錄

第1章 簡介

第2章 調查方法

第3章 執行摘要

第4章 市場動態

  • 促進因素、限制因素、機會與挑戰分析
  • COVID-19 對市場的影響

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭形勢

  • 製造地、銷售區域、產品類型分佈
  • 併購、聯盟、產品發布、合作

第7章 胰島素輸送設備市場：依類型

  • 全球市佔率及預測
  • 胰島素筆針
  • 胰島素幫浦
  • 胰島素注射器
  • 胰島素筆針

第8章 胰島素輸送設備市場：依最終用戶分類

  • 全球市佔率及預測
  • 醫院/診所
  • 病人/居家照護

第9章 胰島素輸送裝置市場預測

  • 市場規模、市場佔有率

第10章 胰島素輸送設備市場：依類型

  • 市場規模、市場佔有率趨勢、預測

第11章 胰島素輸送設備市場：依最終用戶分類

  • 市場規模、市場佔有率趨勢、預測

第12章 胰島素輸送設備市場：依地區

  • 市場規模、市場佔有率趨勢、預測
  • 東部
  • 西部
  • 北部
  • 南部

第13章 公司簡介

  • Biocon Limited
  • Diabetes Care Business
  • Eli Lilly and Company
  • Hindustan Syringes & Medical Devices Ltd.
  • Insulet Corporation
  • Mannkind Corporation
  • Sanofi
  • Terumo Corporation
  • Vicentra BV
  • Others

第14章 簡稱表

第15章 參考鏈接

第16章 結論

第17章 研究範圍

簡介目錄
Product Code: HLCA2417

Insulin Delivery Devices Market Introduction and Overview

According to SPER market research, 'Insulin Delivery Devices Market Size- By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Insulin Delivery Devices Market is predicted to reach USD 70.14 billion by 2033 with a CAGR of 8.71%.

The beta cells in the islets of Langerhans of the pancreas produce the hormone insulin. By promoting cellular glucose uptake and controlling the metabolism of fats, proteins, and carbohydrates, the hormone keeps blood glucose levels within normal ranges. Type I and type II diabetes can be brought on by inappropriate insulin function brought on by damaged beta cells or the body's incapacity to utilize the insulin that is produced.

Furthermore, the market for insulin delivery devices was significantly impacted by the COVID-19 pandemic. Patients with type 1 diabetes are more affected by COVID-19. Due to their already compromised immune systems, people with diabetes quickly deteriorate when exposed to COVID-19. Individuals with diabetes may be more susceptible than healthy individuals to major complications.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2033

Base year considered 2022

Forecast period 2023-2033

Segments covered By Type, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Biocon Limited, Eli Lilly and Company, Hindustan Syringes & Medical Devices Ltd, Insulet Corporation, Mannkind Corporation, Medtronic, Sanofi, Terumo Corporation, and Vicentra B.V.

Insulin Delivery Devices Market Segmentation:

By Type: Based on the Method type, Insulin Delivery Devices Market is segmented as; Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standards & Safety).

By End User: Based on the End User, Insulin Delivery Devices Market is segmented as; (Hospitals & Clinics, Patients & Homecare).

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Insulin Delivery Devices Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Insulin Delivery Devices Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Insulin Delivery Devices Market

7. Insulin Delivery Devices Market, By Type (USD Million)

  • 7.1. Insulin Delivery Devices Market Value Share and Forecast, By Type, 2023-2033
  • 7.2. Insulin Pens
  • 7.3. Insulins Pumps
  • 7.4. Insulin Syringes
  • 7.5. Insulin Pen Needles

8. Insulin Delivery Devices Market, By End User (USD Million)

  • 8.1. Insulin Delivery Devices Market Value Share and Forecast, By Vehicle type, 2023-2033
  • 8.2. Hospitals & Clinics
  • 8.3. Patients & Homecare

9. Insulin Delivery Devices Market Forecast, 2019-2033 (USD Million)

  • 9.1. Insulin Delivery Devices Market Size and Market Share

10. Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)

  • 10.1. Insulin Delivery Devices Market Size and Market Share By Type (2019-2026)
  • 10.2. Insulin Delivery Devices Market Size and Market Share By Type (2027-2033)

11. Insulin Delivery Devices Market, By End User, 2019-2033 (USD Million)

  • 11.1. Insulin Delivery Devices Market Size and Market Share By End User (2019-2026)
  • 11.2. Insulin Delivery Devices Market Size and Market Share By End User (2027-2033)

12. Insulin Delivery Devices Market, By Region, 2019-2033 (USD Million)

  • 12.1. Insulin Delivery Devices Market Size and Market Share By Region (2019-2026)
  • 12.2. Insulin Delivery Devices Market Size and Market Share By Region (2027-2033)
  • 12.3. Eastern Region
  • 12.4. Western Region
  • 12.5. Northern Region
  • 12.6. Southern Region

13. Company Profile

  • 13.1. Biocon Limited
    • 13.1.1. Company details
    • 13.1.2. Financial outlook
    • 13.1.3. Product summary
    • 13.1.4. Recent developments
  • 13.2. Diabetes Care Business
    • 13.2.1. Company details
    • 13.2.2. Financial outlook
    • 13.2.3. Product summary
    • 13.2.4. Recent developments
  • 13.3. Eli Lilly and Company
    • 13.3.1. Company details
    • 13.3.2. Financial outlook
    • 13.3.3. Product summary
    • 13.3.4. Recent developments
  • 13.4. Hindustan Syringes & Medical Devices Ltd.
    • 13.4.1. Company details
    • 13.4.2. Financial outlook
    • 13.4.3. Product summary
    • 13.4.4. Recent developments
  • 13.5. Insulet Corporation
    • 13.5.1. Company details
    • 13.5.2. Financial outlook
    • 13.5.3. Product summary
    • 13.5.4. Recent developments
  • 13.6. Mannkind Corporation
    • 13.6.1. Company details
    • 13.6.2. Financial outlook
    • 13.6.3. Product summary
    • 13.6.4. Recent developments
  • 13.7. Sanofi
    • 13.7.1. Company details
    • 13.7.2. Financial outlook
    • 13.7.3. Product summary
    • 13.7.4. Recent developments
  • 13.8. Terumo Corporation
    • 13.8.1. Company details
    • 13.8.2. Financial outlook
    • 13.8.3. Product summary
    • 13.8.4. Recent developments
  • 13.9. Vicentra B.V.
    • 13.9.1. Company details
    • 13.9.2. Financial outlook
    • 13.9.3. Product summary
    • 13.9.4. Recent developments
  • 13.10. Others

14. List of Abbreviations

15. Reference Links

16. Conclusion

17. Research Scope